Influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis
Yang, C.-B.; Chen, Y.; Jin, H.-M.; Ying, W.-W.
Zhongguo Zhong Yao Za Zhi 33(5): 567-569
2008
ISSN/ISBN: 1001-5302 PMID: 18536386 Document Number: 617030
To observe the influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis. A total of 54 patients with endometriosis and without medical complications were random selected. Xianglingwan was administered from the fifth day of the menstrual cycle for 3 weeks every month as a therapeutic course, and three months for a therapeutic period. Pelvic type B ultrasonograph and blood CA125 were detected before and after treatment. Visual analogue scale was admitted to evaluate the dysmenorrhea. The serum CA125 reduced obviously after therapy. There was a significant difference between them (P < 0.01). The symptom of dysmenorrhea also reduced obviously after treatment. There was a significant difference between them (P < 0.05). Xianglingwan can treat edometriosis effectively, and has less adverse reactions, it can also reduce the symptom of dysmenorrheal and the serum CA125.